Hui Wang

机构：Peking University, Canterbury Health Laboratories, Peking University People's Hospital, China Agricultural University · ORCID：0000-0001-9010-4994

发表论文 9 篇 · 总被引 66 次 · h-index 3

代表论文

• In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China (2019 · BMC Infectious Diseases · 被引 41)
• Clinical Impact of Plasma Metagenomic Next-Generation Sequencing on Infection Diagnosis and Antimicrobial Therapy in Immunocompromised Patients (2024 · The Journal of Infectious Diseases · 被引 15)
• Establishing the Comprehensive Structure−Activity Relationship of the Natural Antibiotic Kibdelomycin/Amycolamicin (2024 · Angewandte Chemie International Edition · 被引 3)
• Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy (2024 · Frontiers in Pharmacology · 被引 3)
• Balanced generation of holes and superoxide radicals on Bi 25 CoO 40 sillenite photocatalysts for rapid synergetic degradation of quinolone antibiotics (2024 · Environmental Science Nano · 被引 3)
• Elucidating adaptive compensatory tigecycline resistance mechanisms of RamA, RarA and SoxS in Klebsiella pneumoniae (2025 · International Journal of Antimicrobial Agents · 被引 1)